Last 12 months
Inside the activity.
0 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 03, 2022 Filed Oct 4, 2022 21:37 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
GrantStock Option (Right to Buy) · Derivative | 61,469 | $0.00 Strike: $128.51 | $0.00 |
DisclosureSEC source: 0001127602-22-023567 · form4.xml · derivative · entry 4 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,469 Underlying: Common Stock · 61,469 shares Expires 2032-10-01 Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 14:51 UTC |
Schulten AndreChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 37,892 | $0.00 Strike: $128.51 | $0.00 |
DisclosureSEC source: 0001127602-22-023617 · form4.xml · derivative · entry 3 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,892 Underlying: Common Stock · 37,892 shares Expires 2032-10-01 Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 14:51 UTC |
Schulten AndreChief Financial Officer
|
GrantCommon Stock | 8,755 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023617 · form4.xml · nonDerivative · entry 1 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,085.3382 F1 · price: Restricted Stock Units awarded pursuant to issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 14:53 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
GrantStock Option (Right to Buy) · Derivative | 21,456 | $0.00 Strike: $128.51 | $0.00 |
DisclosureSEC source: 0001127602-22-023618 · form4.xml · derivative · entry 4 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,456 Underlying: Common Stock · 21,456 shares Expires 2032-10-01 Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 14:53 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
GrantCommon Stock | 4,957 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023618 · form4.xml · nonDerivative · entry 1 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,209.5798 F1 · price: Restricted Stock Units awarded pursuant to Issuer's 2019 Stock and Incentive Plan. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 14:55 UTC |
Jejurikar ShaileshChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 42,102 | $0.00 Strike: $128.51 | $0.00 |
DisclosureSEC source: 0001127602-22-023619 · form4.xml · derivative · entry 6 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,102 Underlying: Common Stock · 42,102 shares Expires 2032-10-01 Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 14:55 UTC |
Jejurikar ShaileshChief Operating Officer
|
GrantCommon Stock | 9,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023619 · form4.xml · nonDerivative · entry 1 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,006.289 F1 · price: Restricted Stock Units awarded pursuant to Issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 15:03 UTC |
Pritchard Marc S.Chief Brand Officer
|
GrantStock Option (Right to Buy) · Derivative | 51,462 | $0.00 Strike: $128.51 | $0.00 |
DisclosureSEC source: 0001127602-22-023621 · form4.xml · derivative · entry 7 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,462 Underlying: Common Stock · 51,462 shares Expires 2032-10-01 Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 14:57 UTC |
Raman Sundar G.CEO-Fabric & Home Care
|
GrantStock Option (Right to Buy) · Derivative | 58,396 | $0.00 Strike: $128.51 | $0.00 |
DisclosureSEC source: 0001127602-22-023620 · form4.xml · derivative · entry 3 Raman Sundar G. · CIK 0001882672 · CEO-Fabric & Home Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,396 Underlying: Common Stock · 58,396 shares Expires 2032-10-01 Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 15:09 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantStock Option (Right to Buy) · Derivative | 10,525 | $0.00 Strike: $128.51 | $0.00 |
DisclosureSEC source: 0001127602-22-023622 · form4.xml · derivative · entry 6 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 10,525 Underlying: Common Stock · 10,525 shares Expires 2032-10-01 Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 15:09 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantStock Option (Right to Buy) · Derivative | 49,038 | $0.00 Strike: $128.51 | $0.00 |
DisclosureSEC source: 0001127602-22-023622 · form4.xml · derivative · entry 5 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,038 Underlying: Common Stock · 49,038 shares Expires 2032-10-01 Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 15:09 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantCommon Stock | 811 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023622 · form4.xml · nonDerivative · entry 2 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 8,652.145 F1 · price: Restricted Stock Units awarded pursuant to issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 15:09 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantCommon Stock | 3,777 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023622 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,990.0645 F1 · price: Restricted Stock Units awarded pursuant to issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 15:10 UTC |
Janzaruk Matthew W.SVP - Chief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 8,488 | $0.00 Strike: $128.51 | $0.00 |
DisclosureSEC source: 0001127602-22-023623 · form4.xml · derivative · entry 3 Janzaruk Matthew W. · CIK 0001910008 · SVP - Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,488 Underlying: Common Stock · 8,488 shares Expires 2032-10-01 Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 16:10 UTC |
Coombe Gary ACEO - Grooming
|
GrantStock Option (Right to Buy) · Derivative | 31,156 | $0.00 Strike: $128.51 | $0.00 |
DisclosureSEC source: 0001127602-22-023627 · form4.xml · derivative · entry 4 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,156 Underlying: Common Stock · 31,156 shares Expires 2032-10-01 Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 16:10 UTC |
Coombe Gary ACEO - Grooming
|
GrantCommon Stock | 7,198 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-023627 · form4.xml · nonDerivative · entry 1 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,686.8984 F1 · price: Restricted Stock Units awarded pursuant to issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| October 03, 2022 Filed Oct 5, 2022 16:12 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
GrantStock Option (Right to Buy) · Derivative | 42,557 | $128.51 Strike: $128.51 | $5,469,000.07 |
DisclosureSEC source: 0001127602-22-023628 · form4.xml · derivative · entry 4 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,557 Underlying: Common Stock · 42,557 shares Expires 2032-10-01 Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 14:16 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
GrantStock Option (Right to Buy) · Derivative | 13,343 | $0.00 Strike: $137.44 | $0.00 |
DisclosureSEC source: 0001127602-22-022593 · form4.xml · derivative · entry 4 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,343 Underlying: Common Stock · 13,343 shares Expires 2032-09-15 Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 14:19 UTC |
Jejurikar ShaileshChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 56,618 | $0.00 Strike: $137.44 | $0.00 |
DisclosureSEC source: 0001127602-22-022594 · form4.xml · derivative · entry 6 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,618 Underlying: Common Stock · 56,618 shares Expires 2032-09-15 Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 14:21 UTC |
Keith R. AlexandraCEO - Beauty
|
GrantStock Option (Right to Buy) · Derivative | 33,968 | $0.00 Strike: $137.44 | $0.00 |
DisclosureSEC source: 0001127602-22-022596 · form4.xml · derivative · entry 5 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,968 Underlying: Common Stock · 33,968 shares Expires 2032-09-15 Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 14:26 UTC |
Schulten AndreChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 44,149 | $0.00 Strike: $137.44 | $0.00 |
DisclosureSEC source: 0001127602-22-022597 · form4.xml · derivative · entry 3 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,149 Underlying: Common Stock · 44,149 shares Expires 2032-09-15 Read SEC document |
| September 13, 2022 Filed Sep 15, 2022 14:15 UTC |
Allen Bertrand MarcDirector
|
GrantCommon Stock | 218 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-022431 · form4.xml · nonDerivative · entry 1 Allen Bertrand Marc · CIK 0001632131 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,826.599 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| September 13, 2022 Filed Sep 15, 2022 14:18 UTC |
Braly Angela FDirector
|
GrantCommon Stock | 254 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-022432 · form4.xml · nonDerivative · entry 1 Braly Angela F · CIK 0001321458 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,956.4899 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| September 13, 2022 Filed Sep 15, 2022 14:20 UTC |
JIMENEZ JOSEPHDirector
|
GrantCommon Stock | 290 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-022433 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,900.3539 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| September 13, 2022 Filed Sep 15, 2022 14:21 UTC |
Kempczinski Christopher JDirector
|
GrantCommon Stock | 218 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-022435 · form4.xml · nonDerivative · entry 1 Kempczinski Christopher J · CIK 0001598115 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,058.9069 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| September 13, 2022 Filed Sep 15, 2022 14:23 UTC |
LUNDGREN TERRY JDirector
|
GrantCommon Stock | 263 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-022437 · form4.xml · nonDerivative · entry 1 LUNDGREN TERRY J · CIK 0001184471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,479.7016 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| September 13, 2022 Filed Sep 15, 2022 14:24 UTC |
McCarthy Christine MDirector
|
GrantCommon Stock | 218 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-022438 · form4.xml · nonDerivative · entry 1 McCarthy Christine M · CIK 0001332169 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,165.2473 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock & Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| September 13, 2022 Filed Sep 15, 2022 14:26 UTC |
WOERTZ PATRICIA ADirector
|
GrantCommon Stock | 272 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-022439 · form4.xml · nonDerivative · entry 1 WOERTZ PATRICIA A · CIK 0001194945 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,210.4555 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 26, 2022 Filed Aug 29, 2022 13:46 UTC |
Grabowski Mary TheresaChief Human Resources Officer
|
SaleCommon Stock | 10,397 | $146.00 | $1,517,962.00 |
DisclosureSEC source: 0001127602-22-021656 · form4.xml · nonDerivative · entry 1 Grabowski Mary Theresa · CIK 0001747030 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,352.9806 Read SEC document |
| August 23, 2022 Filed Aug 24, 2022 12:53 UTC |
Davis Jennifer L.CEO - Health Care
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 27,809 | $0.00 Strike: $91.07 | $0.00 |
DisclosureSEC source: 0001127602-22-021507 · form4.xml · derivative · entry 4 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,809 shares Expires 2027-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2022 Filed Aug 24, 2022 12:53 UTC |
Davis Jennifer L.CEO - Health Care
|
SaleCommon Stock | 27,809 | $147.95 | $4,114,341.55 |
DisclosureSEC source: 0001127602-22-021507 · form4.xml · nonDerivative · entry 2 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,894.7879 Read SEC document |
| August 23, 2022 Filed Aug 24, 2022 12:53 UTC |
Davis Jennifer L.CEO - Health Care
|
Exercise / conversionCommon Stock | 27,809 | $91.07 | $2,532,565.63 |
DisclosureSEC source: 0001127602-22-021507 · form4.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,703.7879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2022 Filed Aug 22, 2022 14:05 UTC |
Coombe Gary ACEO - Grooming
|
SaleCommon Stock | 12,930 | $149.21 | $1,929,285.30 |
DisclosureSEC source: 0001127602-22-021415 · form4.xml · nonDerivative · entry 1 Coombe Gary A · CIK 0001623622 · CEO - Grooming 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,488.8984 F1 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 18, 2022 Filed Aug 19, 2022 15:34 UTC |
Jejurikar ShaileshChief Operating Officer
|
SaleCommon Stock | 18,981 | $148.87 | $2,825,701.47 |
DisclosureSEC source: 0001127602-22-021351 · form4.xml · nonDerivative · entry 1 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279.289 Read SEC document |
| August 18, 2022 Filed Aug 19, 2022 15:35 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 1,289 | $149.15 | $192,254.35 |
DisclosureSEC source: 0001127602-22-021352 · form4.xml · nonDerivative · entry 2 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 7,841.145 Read SEC document |
| August 18, 2022 Filed Aug 19, 2022 15:35 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 17,347 | $148.92 | $2,583,327.38 |
DisclosureSEC source: 0001127602-22-021352 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,213.0645 F1 · price: Weighted average price of the shares sold. The price range was $148.9201 to $148.95. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 16:41 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 1,080 | $149.33 | $161,275.75 |
DisclosureSEC source: 0001127602-22-021274 · form4.xml · nonDerivative · entry 4 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 9,130.145 F3 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 16:41 UTC |
Keith R. AlexandraCEO - Beauty
|
SaleCommon Stock | 14,530 | $149.33 | $2,169,756.18 |
DisclosureSEC source: 0001127602-22-021274 · form4.xml · nonDerivative · entry 3 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,560.0645 F3 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 16:42 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
SaleCommon Stock | 29,405 | $149.33 | $4,391,031.01 |
DisclosureSEC source: 0001127602-22-021275 · form4.xml · nonDerivative · entry 4 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,223.7802 F3 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 16:42 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
SaleCommon Stock | 767 | $149.33 | $114,535.65 |
DisclosureSEC source: 0001127602-22-021275 · form4.xml · nonDerivative · entry 3 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 35,377.7778 F3 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 16:43 UTC |
Grabowski Mary TheresaChief Human Resources Officer
|
SaleCommon Stock | 8,624 | $149.33 | $1,287,816.75 |
DisclosureSEC source: 0001127602-22-021276 · form4.xml · nonDerivative · entry 2 Grabowski Mary Theresa · CIK 0001747030 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,749.9806 F3 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 16:45 UTC |
Jejurikar ShaileshChief Operating Officer
|
SaleCommon Stock | 12,426 | $149.33 | $1,855,567.12 |
DisclosureSEC source: 0001127602-22-021278 · form4.xml · nonDerivative · entry 2 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,260.289 F3 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 16:46 UTC |
Davis Jennifer L.CEO - Health Care
|
SaleCommon Stock | 7,621 | $149.33 | $1,138,039.36 |
DisclosureSEC source: 0001127602-22-021279 · form4.xml · nonDerivative · entry 2 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,894.7879 F3 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 16:47 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
SaleCommon Stock | 12,252 | $149.33 | $1,829,583.81 |
DisclosureSEC source: 0001127602-22-021280 · form4.xml · nonDerivative · entry 2 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,331.1275 F3 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 16:49 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
SaleCommon Stock | 1,067 | $149.33 | $159,334.47 |
DisclosureSEC source: 0001127602-22-021282 · form4.xml · nonDerivative · entry 2 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,473.3174 F3 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 17:41 UTC |
Schulten AndreChief Financial Officer
|
SaleCommon Stock | 987 | $149.33 | $147,388.12 |
DisclosureSEC source: 0001127602-22-021284 · form4.xml · nonDerivative · entry 2 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,330.3382 F3 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 16:52 UTC |
Raman Sundar G.CEO-Fabric & Home Care
|
SaleCommon Stock | 6,958 | $149.33 | $1,039,033.97 |
DisclosureSEC source: 0001127602-22-021283 · form4.xml · nonDerivative · entry 4 Raman Sundar G. · CIK 0001882672 · CEO-Fabric & Home Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,310.0106 F4 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 17:42 UTC |
Pritchard Marc S.Chief Brand Officer
|
SaleCommon Stock | 12,228 | $149.33 | $1,825,999.90 |
DisclosureSEC source: 0001127602-22-021285 · form4.xml · nonDerivative · entry 2 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,158.0481 F3 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 17:43 UTC |
Whaley Susan StreetChief Legal Officer & Secy
|
SaleCommon Stock | 907 | $149.33 | $135,441.77 |
DisclosureSEC source: 0001127602-22-021286 · form4.xml · nonDerivative · entry 2 Whaley Susan Street · CIK 0001929158 · Chief Legal Officer & Secy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,252.5798 F3 · shares: Shares sold to cover taxes on Stock Award. Read SEC document |
| August 16, 2022 Filed Aug 16, 2022 20:37 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 58,538 | $0.00 Strike: $80.29 | $0.00 |
DisclosureSEC source: 0001127602-22-021090 · form4.xml · derivative · entry 8 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 58,538 shares Expires 2026-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.